Monthly Archives: April 2012

Is DMAA forcing FDA’s hand on NDIs?

On April 27, 2012, marked the first time that the U.S. Food & Drug Administration (FDA) has sent warning letters with NDI-related language since 2010, prompting industry to wonder: Has NDI enforcement arrived? In 2010, the agency warned supplement maker Unlimited Nutrition that its products contained piracetam—a nootropic drug—that did not meet the definition of…

Continue reading